Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GANESHA ECOSPHERE Quarterly Results  (GPLY)



Here are the latest quarterly results of GANESHA ECOSPHERE. For more details, see the GANESHA ECOSPHERE financial fact sheet and GANESHA ECOSPHERE share price. For a sector overview, read our textiles sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GANESHA ECOSPHERE Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-22
*
3
Jun-22
*
3
Sep-22
*
3
Dec-22
*
3
Mar-23
*
3
Jun-23
*
3
Sep-23
*
3
Dec-23
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,8712,9263,1292,7263,0152,5412,7842,848 
Other income Rs m159187235293240 
Turnover Rs m2,8862,9353,1472,7973,0512,5712,8172,888 
Expenses Rs m2,5432,6562,7802,4052,6782,2862,5312,449 
Gross profit Rs m580270349321337255253400 
Depreciation Rs m7167676889122124122 
Interest Rs m2227354166114116128 
Profit before tax Rs m5011852662832174845190 
Tax Rs m6052697163141763 
Profit after tax Rs m4411331972111543428127 
Gross profit margin %20.29.211.211.811.210.09.114.0 
Effective tax rate %12.028.125.925.329.128.837.633.0 
Net profit margin %15.44.56.37.75.11.41.04.5 
Diluted EPS Rs 17.4 5.2 7.8 8.3 6.1 1.4 1.1 5.0  
Diluted EPS (TTM) Rs 24.4 34.7 36.9 38.7 27.4 23.5 16.9 13.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster


 

Today's Market

Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.